Russia To Roll Out COVID-19 Vaccine Based On Phase II Data
Study Of Just 76 Subjects Published In Lancet
Early data suggests double adenovirus candidate has promise – but Russia plans key worker vaccinations ahead of pivotal trial.
Early data suggests double adenovirus candidate has promise – but Russia plans key worker vaccinations ahead of pivotal trial.